主页文献库搜索
Investigating the genetic landscape of cancer in Jordan: a step toward person...

Al-Eitan(LN),Tarkhan(AH),Ali(HO),Alasmar(M... Eur J Med Res 2025-07-02

...BRCA1/2 and TP53 among the most frequently mutated genes. While somatic mutations such as KRAS and EGFR were commonly re...

From genetic risk to early detection - clinical outcomes of a person-centered...

Zhou(K),Abadie(C),Crivelli(L),Fortin(E),Be... Front Oncol None

...BRCA1 and BRCA2 pathogenic variants (PV) and women at high risk without BRCA PV, enrolled in eight cancer genetics units...

Brain imaging data and summary data-based Mendelian randomization analysis re...

Han(YK),Liu(MY),Yang(DL),Xie(JX),Wang(XH),... Front Psychiatry None

...BRCA1 DNA repair-associated (BRCA1), MutL homolog 1 (MLH1), vascular endothelial growth factor A (VEGFA), microtubule-as...

Pathologic complete response after neoadjuvant chemotherapy for HER-2 negativ...

Chen(X),Ji(L),Fan(Y),Li(Q),Li(Q),Wang(J),L... Future Oncol 2025-08-00

...BRCA1/2. This retrospective cohort study included HER-2-negative breast cancer patients who completed HRR genetic testin...

Performance Evaluation of a New HRD Assay (HRDsig) in Ovarian Carcinomas in A...

Dorwal(P),Song(L),Siswara(P),Kumar(A),Robi... J Clin Lab Anal 2025-09-00

...BRCA1 and BRCA2, among others, while the PARP-mediated repair pathway is primarily used for single-strand breaks. When a...

Breast carcinomas associated with microglandular adenosis are linked to germl...

Schwartz(CJ),Genco(I),Repetto(M),Muldoon(D... NPJ Breast Cancer 2025-07-22

...BRCA1 (81%, 13/16). Most tumors were grade 3 invasive ductal or metaplastic carcinomas with limited tumor-infiltrating l...

Clinical utility and characteristics of comprehensive genomic profiling tests...

Terada(S),Tanaka(T),Hisamatsu(Y),Kita(M),T... Int J Clin Oncol 2025-10-00

...BRCA1/2, six for ERBB2, and five for PIK3CA. Twenty-five patients died before receiving their CGP results. The objective...

Breast biopsies and breast cancer risk in Israeli BRCA germline pathogenic va...

Madorsky Feldman(D),Sklair-Levy(M),Laitman... Breast Cancer Res Treat 2025-10-00

...BRCA1 and BRCA2 pathogenic variants (PVs) carriers. Female BRCA1 and BRCA2 PV carriers treated at the Meirav Clinic, She...

The use of hormonal contraceptives in a cohort of healthy women with BRCA mut...

Grandi(G),Sgandurra(A),Feliciello(L),Pedri... Eur J Contracept Reprod Hea... 2025-12-00

...BRCA1 vs. BRCA2), in comparison to similar women of the same cohort who were not using HC or had recently undergone risk...

Impact of germline BRCA1/2 status on outcomes for patients with HR+/HER2- met...

Bottosso(M),Zurlo(C),Miglietta(F),Cattelan... Breast 2025-10-00

...BRCA1/2 mutation (gBRCAm) carriers are HR+/HER2-. Sparse data suggest limited CDK4/6 inhibitors benefit among gBRCAm car...

上一页 94 95 96 97 98 99 100 101 102 下一页 98 / 共 1000

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com